Modeling the Clinical and Economic Burden of Therapeutic Inertia in People with Type 2 Diabetes in Saudi Arabia.
Mohammed AlluhidanAbdulrahman AlturaikiHana AlabdulkarimNasser AljehaniEssam A AlghamdiFahad AlsabaanAbdullah A AlamriSamuel J P MalkinBarnaby HuntAbdulaziz AlhossanAhmed Al-JedaiPublished in: Advances in therapy (2024)
Therapeutic inertia was associated with a substantial health and economic burden in Saudi Arabia. Interventions and initiatives that can help to reduce therapeutic inertia are likely to improve health outcomes and reduce healthcare expenditure.